Tag: pipeline

Revid.ai opens its video production pipeline to autonomous AI agents, streamlining the creation process from script to publication.

TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX: NPI) announces it will release its 2026 second quarter operating and financial results after markets close on Wednesday, August 12, 2026. Northland's management will hold an earnings conference call and webcast at 10:00 a.m. Eastern Time (ET) on Thursday, August 13, 2026, followed by a question and answer period with analysts.

ROAD TOWN, British Virgin Islands, July 14, 2026 (GLOBE NEWSWIRE) -- TxFlow L1, the Layer 1 blockchain powering a multi-application onchain financial ecosystem built around its TIP Liquidity Standards, today announced its second Channel: Probly, the first prediction-market application built on TxFlow Improvement Protocol 3 (TIP3).

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

LIKMEZ® (ATI-1501) commercial momentum building in U.S. market

US$40 million NIAID award supporting VXV-01 advancement through Phase 1

WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 65,100 shares of the Company’s ordinary shares to three non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on June 25, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).

Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination

Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.